Compounds > mifepristone
Page last updated: 2024-08-23

mifepristone and HIV Infections

mifepristone has been researched along with HIV Infections in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's3 (33.33)29.6817
2010's4 (44.44)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benton, TD; Blume, J; Douglas, SD; Dubé, B; Evans, DL; Gettes, DR; Lynch, KG; Metzger, DS; Tustin, NB1
Brizz, B; Cavert, W; Daar, ES; Lertora, J; Para, MF; Patterson, KB; Reeds, D; Rosenkranz, SL; Schouten, J; Tebas, P; Weiner, D; White, CJ; Yu, S1
Anzaldi, M; Di Gregorio, P; Di Marco, R; Donia, M; Fagone, P; Galvagna, S; Libra, M; Mangano, K; Nicoletti, F1
Cabrera-Muñoz, E; Camacho-Arroyo, I; Fuentes-Romero, LL; Soto-Ramírez, LE; Zamora-Chávez, J1
Chrousos, GP; Elenkov, I; Hiroi, N; Kino, T; Mirani, M; Volpi, S1
Choo, AY; Emmanuel, J; Hwang, DS; Kumar, S; Madesh, M; Muthumani, K; Premkumar, A; Thieu, KP; Thompson, CB; Weiner, DB; Zong, WX1
Forster, HP1
Szalavitz, M1

Reviews

1 review(s) available for mifepristone and HIV Infections

ArticleYear
Legal trends in bioethics.
    The Journal of clinical ethics, 2000,Winter, Volume: 11, Issue:4

    Topics: Bioethical Issues; Ethicists; Ethics, Medical; Expert Testimony; Genetic Testing; Health Policy; HIV Infections; Humans; Informed Consent; Liability, Legal; Managed Care Programs; Mifepristone; Organ Transplantation; Prejudice; Suicide, Assisted; Twins, Conjoined; United States

2000

Trials

2 trial(s) available for mifepristone and HIV Infections

ArticleYear
Phase I/II trial of the anti-HIV activity of mifepristone in HIV-infected subjects ACTG 5200.
    Journal of acquired immune deficiency syndromes (1999), 2010, Apr-01, Volume: 53, Issue:4

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Mifepristone; Placebos; RNA, Viral; Treatment Outcome; Viral Load; Young Adult

2010
Phase II study of the antiretroviral activity and safety of the glucocorticoid receptor antagonist mifepristone in HIV-1-infected patients.
    International journal of molecular medicine, 2011, Volume: 28, Issue:3

    Topics: Administration, Oral; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Dose-Response Relationship, Drug; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Male; Middle Aged; Mifepristone; Receptors, Glucocorticoid; Viral Load; Young Adult

2011

Other Studies

6 other study(ies) available for mifepristone and HIV Infections

ArticleYear
The glucocorticoid antagonist RU-486 suppresses HIV infectivity and replication.
    The Journal of neuropsychiatry and clinical neurosciences, 2013,Winter, Volume: 25, Issue:1

    Topics: Adolescent; Adult; Cell Line; Depression; Female; HIV Infections; Hormone Antagonists; Humans; Middle Aged; Mifepristone; Psychiatric Status Rating Scales; Retrospective Studies; T-Lymphocytes; Viral Load; Virus Replication; Young Adult

2013
Effects of progesterone on the content of CCR5 and CXCR4 coreceptors in PBMCs of seropositive and exposed but uninfected Mexican women to HIV-1.
    The Journal of steroid biochemistry and molecular biology, 2012, Volume: 132, Issue:1-2

    Topics: Adult; Cells, Cultured; Estradiol; Ethnicity; Female; HIV Infections; HIV Seropositivity; HIV-1; Hormone Antagonists; Humans; Leukocytes, Mononuclear; Middle Aged; Mifepristone; Progesterone; Receptors, CCR5; Receptors, CXCR4; Receptors, Progesterone

2012
Overview.
    State reproductive health monitor : legislative proposals and actions, 1993, Volume: 4, Issue:1

    Topics: Abortion, Induced; Americas; Biology; Consumer Product Safety; Demography; Developed Countries; Disease; Education; Endocrine System; Family Planning Services; Fertility; Health Education; HIV Infections; Hormone Antagonists; Hormones; Informed Consent; Legislation as Topic; Licensure; Mifepristone; North America; Physiology; Population; Population Dynamics; Pregnancy in Adolescence; Sex Education; Sexual Behavior; Third-Party Consent; United States; Virus Diseases

1993
HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection.
    Journal of immunology (Baltimore, Md. : 1950), 2002, Dec-01, Volume: 169, Issue:11

    Topics: Base Sequence; Dexamethasone; DNA, Viral; Gene Products, vpr; Glucocorticoids; HIV Infections; HIV-1; Hormone Antagonists; Humans; Immune Tolerance; Immunity, Cellular; In Vitro Techniques; Interleukin-12; Lipopolysaccharides; Mifepristone; Monocytes; Receptors, Glucocorticoid; Recombinant Proteins; RNA, Messenger; vpr Gene Products, Human Immunodeficiency Virus

2002
The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1.
    Nature cell biology, 2006, Volume: 8, Issue:2

    Topics: Active Transport, Cell Nucleus; Animals; Antigens, Bacterial; Cell Line; Cell Nucleus; Chlorocebus aethiops; Enterotoxins; Female; Gene Expression; Gene Products, vpr; HeLa Cells; HIV Infections; Humans; I-kappa B Kinase; I-kappa B Proteins; Interleukin-1; Interleukin-12; Jurkat Cells; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Mifepristone; Mutation; NF-kappa B; NF-KappaB Inhibitor alpha; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protein Binding; Protein Interaction Mapping; Receptors, Glucocorticoid; RNA, Small Interfering; Transcription Factor RelA; Transfection; Tumor Necrosis Factor-alpha; U937 Cells; vpr Gene Products, Human Immunodeficiency Virus

2006
RU-486. Anti-choice extremists block HIV drug research.
    Notes from the underground (New York, N.Y.), 1999,Spring, Issue:No 39

    Topics: Abortifacient Agents, Steroidal; Abortion, Legal; Anti-HIV Agents; Chemistry, Pharmaceutical; Clinical Trials as Topic; Female; HIV Infections; Humans; Mifepristone; Pregnancy; Social Justice; United States

1999